Blennow K - Search Results

1

Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease.

Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N, Andreasen N, Lenhard B, Brookes AJ, Pedersen NL, Blennow K, Prince JA. Johansson A, et al. Among authors: blennow k. Hum Genet. 2004 May;114(6):581-7. doi: 10.1007/s00439-004-1107-9. Epub 2004 Mar 18. Hum Genet. 2004. PMID: 15034781

2

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Blennow K, Hesse C, Fredman P. Blennow K, et al. Neuroreport. 1994 Dec 20;5(18):2534-6. doi: 10.1097/00001756-199412000-00032. Neuroreport. 1994. PMID: 7696597

3

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L. Blennow K, et al. Int Psychogeriatr. 1994 Spring;6(1):13-22; discussion 59-60. doi: 10.1017/s1041610294001584. Int Psychogeriatr. 1994. PMID: 8054491

4

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Blennow K, et al. Mol Chem Neuropathol. 1995 Dec;26(3):231-45. doi: 10.1007/BF02815140. Mol Chem Neuropathol. 1995. PMID: 8748926

5

Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.

Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P. Blennow K, et al. J Neural Transm (Vienna). 1996;103(5):603-18. doi: 10.1007/BF01273157. J Neural Transm (Vienna). 1996. PMID: 8811505

6

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, Blennow K. Skoog I, et al. Among authors: blennow k. Neurodegeneration. 1995 Dec;4(4):433-42. doi: 10.1006/neur.1995.0052. Neurodegeneration. 1995. PMID: 8846237

7

The neurochemistry of Alzheimer's disease.

Blennow K, Cowburn RF. Blennow K, et al. Acta Neurol Scand Suppl. 1996;168:77-86. doi: 10.1111/j.1600-0404.1996.tb00378.x. Acta Neurol Scand Suppl. 1996. PMID: 8997425 Review.

8

Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.

Skoog I, Hesse C, Fredman P, Andreasson LA, Palmertz B, Blennow K. Skoog I, et al. Among authors: blennow k. Arch Neurol. 1997 Mar;54(3):267-72. doi: 10.1001/archneur.1997.00550150029012. Arch Neurol. 1997. PMID: 9074395

9

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, Räihä I, Sourander L, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):298-305. doi: 10.1136/jnnp.64.3.298. J Neurol Neurosurg Psychiatry. 1998. PMID: 9527138 Free PMC article.

10

Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing.

Blennow K, Vanmechelen E. Blennow K, et al. J Neural Transm Suppl. 1998;53:223-35. doi: 10.1007/978-3-7091-6467-9_20. J Neural Transm Suppl. 1998. PMID: 9700660 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,176 results

Search Page

Filters